A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/16552436

Br. J. Cancer 2006 Apr 10 94 7 964-8

Download in:

View as

Triples

General Info

PMID
16552436